Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan O'Brien

Showing results (81-90 of 643) with videos related to

Pageof 65
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 1, 2006
Nocardia veterana bloodstream infection in a patient with cancer and a summary of reported casesShoaib R Ansari, Amar Safdar, Xiang Y Han, et al.
Seminars in Hematology|February 13, 2007
New targeted therapies for chronic myelogenous leukemia: opportunities to overcome imatinib resistanceElias Jabbour, Jorge Cortes, Susan O'Brien, et al.
Future Oncology (London, England)|August 2, 2013
Elacytarabine (CP-4055) in the treatment of acute myeloid leukemiaCourtney D DiNardo, Susan O'Brien, Varsha V Gandhi, et al.
Seminars in Hematology|November 20, 2013
Targeted therapies in hematology and their impact on patient care: chronic and acute myeloid leukemiaElias Jabbour, Jorge Cortes, Farhad Ravandi, et al.
Leukemia & Lymphoma|October 25, 2016
MLL-rearranged mixed phenotype acute leukemia masquerading as B-cell ALLWei Yang, Phu Tran, Ziad Khan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 13, 2015
The need for United States-based guidelines for myeloproliferative neoplasmsBrady L Stein, Susan O'Brien, Peter Greenberg, et al.
Idrugs : the Investigational Drugs Journal|July 21, 2007
Drug evaluation: Nilotinib - a novel Bcr-Abl tyrosine kinase inhibitor for the treatment of chronic myelocytic leukemia and beyondElias Jabbour, Jorge Cortes, Francis Giles, et al.
British Journal of Haematology|January 22, 2023
How we approach the perioperative management of patients with chronic lymphocytic leukaemia receiving continuous cancer-directed therapiesHelen Ma, Stephani Wang, Susan O'Brien, et al.
Pediatric Blood & Cancer|September 4, 2013
Initial experience with CMC-544 (inotuzumab ozogamicin) in pediatric patients with relapsed B-cell acute lymphoblastic leukemiaMichael Rytting, Lisa Triche, Deborah Thomas, et al.
Expert Review of Hematology|November 13, 2014
Ibrutinib: a paradigm shift in management of CLLTalha Badar, Jan A Burger, William G Wierda, et al.
Pageof 65

Showing results (81-90 of 643) with videos related to

Sort By:
Pageof 65
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 1, 2006
Nocardia veterana bloodstream infection in a patient with cancer and a summary of reported casesShoaib R Ansari, Amar Safdar, Xiang Y Han, et al.
Seminars in Hematology|February 13, 2007
New targeted therapies for chronic myelogenous leukemia: opportunities to overcome imatinib resistanceElias Jabbour, Jorge Cortes, Susan O'Brien, et al.
Future Oncology (London, England)|August 2, 2013
Elacytarabine (CP-4055) in the treatment of acute myeloid leukemiaCourtney D DiNardo, Susan O'Brien, Varsha V Gandhi, et al.
Seminars in Hematology|November 20, 2013
Targeted therapies in hematology and their impact on patient care: chronic and acute myeloid leukemiaElias Jabbour, Jorge Cortes, Farhad Ravandi, et al.
Leukemia & Lymphoma|October 25, 2016
MLL-rearranged mixed phenotype acute leukemia masquerading as B-cell ALLWei Yang, Phu Tran, Ziad Khan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 13, 2015
The need for United States-based guidelines for myeloproliferative neoplasmsBrady L Stein, Susan O'Brien, Peter Greenberg, et al.
Idrugs : the Investigational Drugs Journal|July 21, 2007
Drug evaluation: Nilotinib - a novel Bcr-Abl tyrosine kinase inhibitor for the treatment of chronic myelocytic leukemia and beyondElias Jabbour, Jorge Cortes, Francis Giles, et al.
British Journal of Haematology|January 22, 2023
How we approach the perioperative management of patients with chronic lymphocytic leukaemia receiving continuous cancer-directed therapiesHelen Ma, Stephani Wang, Susan O'Brien, et al.
Pediatric Blood & Cancer|September 4, 2013
Initial experience with CMC-544 (inotuzumab ozogamicin) in pediatric patients with relapsed B-cell acute lymphoblastic leukemiaMichael Rytting, Lisa Triche, Deborah Thomas, et al.
Expert Review of Hematology|November 13, 2014
Ibrutinib: a paradigm shift in management of CLLTalha Badar, Jan A Burger, William G Wierda, et al.
Pageof 65